Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel PI3K and mTOR inhibitors patented by Pathway Therapeutics

Oct. 23, 2012

Novel GABA(A) receptor modulators synthesized by team of French researchers

Oct. 22, 2012

MRC Technology presents new antimalarials

Oct. 22, 2012

Novel candidate anticancer drugs patented

Oct. 22, 2012

Research at Ortho-McNeil-Janssen Pharmaceuticals yields new gamma secretase modulators

Oct. 22, 2012

Ono Pharmaceutical designs novel E-NPP 2 inhibitors

Oct. 22, 2012

Japanese Foundation for Cancer Research presents new antibodies

Oct. 19, 2012

Hyundai Pharmaceutical patents new 11-beta-HSD1 inhibitors

Oct. 19, 2012

New IL-7A proteins prepared at the University of Central Florida

Oct. 19, 2012

Trevena divulges new opioid receptor ligands

Oct. 19, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...